Three-Dimensional Correction Methods for Idiopathic Scoliosis in Adolescent

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age13-18
SponsorCairo University

About this trial

This study aims to compare the effectiveness of "Schroth method" and "Scientific Exercise Approach to Scoliosis" for correcting idiopathic scoliosis in adolescents.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Teenagers diagnosed with typical idiopathic scoliosis.

Teenagers aged 13 to 18 years

Both genders will be included.

Participants with a Cobb angle ranging from 10° to 25°, as determined by radiographic analysis.

Disqualifiers

Adolescents with significant visual or auditory impairments that could interfere with the ability to participate in or benefit from the rehabilitation programs.

Adolescents with cognitive, mental, or psychological disorders that hinder understanding or following the instructions necessary for the treatment protocol.

Adolescents who have previously undergone spinal surgery or any surgical interventions related to scoliosis or other spinal conditions.

Adolescents with non-idiopathic scoliosis or scoliosis secondary to other underlying conditions (e.g., neuromuscular, congenital, or syndromic scoliosis).

Trial design

Design model

Parallel

Treatments tested in this trial

  • Schroth treatment

    Other intervention

    The exercise program targets three-dimensional spinal correction and includes Schroth breathing for rib cage expansion, pelvic tilts for pelvic alignment, side-shift exercises for lateral correction, rotational angular breathing for derotation, seated rotational stretches for lumbar flexibility, trunk elongation with resistance for postural strength, hanging stretches for spinal decompression, and arm-leg lifts to enhance core stability and coordination.

  • Scientific Exercise Approach to Scoliosis (SEAS)

    Other intervention

    The SEAS exercise program emphasizes active self-correction, core stability, and postural control during functional movements. Key exercises include pelvic tilts, seated forward bends, standing side bends, supine marching, bird-dog, heel slides, chest openers, and supine knee-to-chest stretches, all performed with self-correction to maintain neutral spinal alignment, improve muscular control, flexibility, and long-term postural stability.

Treatment groups

30 Participants
are divided into 2 treatment groups
Group A: Schroth treatmentExperimental treatment 1 intervention
Group B: Scientific Exercise Approach to Scoliosis (SEAS)Experimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Cobb Angle

It will be assessed using standard standing posteroanterior spinal radiographs and will be measured before and after the intervention period. This outcome measure will be used to quantify the magnitude of the lateral spinal curvature and to evaluate changes in spinal alignment, allowing determination of the degree of curve correction or progression following the intervention.

Time frame
12 weeks
2

Angle of Trunk Rotation (ATR)

It will be measured using a scoliometer during the Adam's forward bend test and will be assessed before and after the intervention period. This outcome measure will be used to evaluate the degree of rotational trunk deformity, reflecting the axial component of the three-dimensional spinal deformity in scoliosis.

Time frame
12 weeks

Secondary outcomes

1

Risser Sign

It will be evaluated using pelvic radiographs and will serve as an indicator of skeletal maturity. This outcome measure will be used to estimate remaining growth potential and to assess the risk of scoliosis curve progression during the growth period.

Time frame
12 weeks
2

Health-Related Quality of Life (HRQOL)

It will be assessed using validated Arabic versions of the Scoliosis Research Society-22 (SRS-22) questionnaire or the Pediatric Quality of Life Inventory (PedsQL). These instruments will be used to evaluate multiple domains affected by scoliosis, including pain, functional status, self-image, emotional well-being, and social functioning, providing a comprehensive measure of patients' perceived health and overall quality of life.

Time frame
12 weeks

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: